Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer	Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm	Active, not recruiting	Phase 1	2026-01-06		NCT02560636

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Cancer Research, United Kingdom	59
Merck Sharp & Dohme LLC	650
National Institute for Health Research, United Kingdom	75
Royal Marsden NHS Foundation Trust	89

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
NIHR Biomedical Research Centre at RM and ICR (https://www.cancerbrc.org/)	Sutton	United Kingdom	1

Clinical trials